Clinical trial Recruiting at 5 sites Observational

Allay Hydrogel Cap: Safety and Performance in Peripheral Nerve Surgery

Official title: Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success (COMPASS) Study: An Open Label Registry Study to Assess the Safety and Performance of the Allay™ Hydrogel Cap

Run by Tulavi Therapeutics,Inc. · NCT07246980 · Data updated 2026-11-12

This registry is watching how well the Allay Hydrogel Cap works and how safe it is for people who have peripheral nerve injuries and get the cap during surgery.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorTulavi Therapeutics,Inc.
Industry-sponsored
Locations5 sites (Redwood City, California and 4 other locations)
StatusRecruiting
StartedMay 6, 2026
Main results expectedJanuary 1, 2029
Study endsMay 1, 2029
Registry record updatedSeptember 21, 2026
Trial IDNCT07246980 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with peripheral nerve injuries who have or will receive the Allay Hydrogel Cap at participating sites.

Probably not a fit

Patients who do not receive the Allay Hydrogel Cap or who are not treated at participating sites may not see any benefit evaluated by this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, open-label observational registry (prospective and retrospective) to collect safety and performance data on the Allay Hydrogel Cap used in peripheral nerve procedures such as amputation and neuroma excision. The study tracks demographic and operative information along with patient-reported outcomes like pain, pain tolerance, cold intolerance, neuroma recurrence, and changes in pain medication from baseline. Secondary endpoints monitor device failures, surgical complications, unplanned re-operations, and unexpected adverse device events. Data are gathered from participating sites to understand real-world use and outcomes of the device.

Why it matters

Potential benefit: If successful, findings could clarify real-world safety and performance of the Allay Hydrogel Cap and guide future clinical use.

How similar studies have gone: Previous observational registries for similar implants have helped characterize safety and usage patterns, though results can vary by practice setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have or will receive allay™ Hydrogel Cap

Exclusion Criteria:

* Patients who have not received allay™ Hydrogel Cap

Where it's running

  • Kaiser Permanente
    Redwood City, California, United States
    Recruiting
  • University of Colorado Anschutz.
    Englewood, Colorado, United States
    Recruiting
  • Orlando Health
    Orlando, Florida, United States
    Recruiting
  • Florida Orthopedic Institute
    St. Petersburg, Florida, United States
    Recruiting
  • Complete Foot and Ankle Care of North Texas, PA
    Denton, Texas, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.